Cargando…
Recombinant Costimulatory Fusion Proteins as Functional Immunomodulators Enhance Antitumor Activity in Murine B16F10 Melanoma
Blocking inhibitory signaling and engaging stimulatory signaling have emerged as important therapeutic modalities for cancer immunotherapy. This study aimed to investigate immunomodulatory features of three recombinant costimulatory ligand proteins in a mouse model, which are extracellular domains o...
Autores principales: | Cai, Huaman, Wang, Wenfang, Lin, Zhibing, Zhang, Yan, Wu, Bing, Wan, Yuhua, Li, Rongxiu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7349950/ https://www.ncbi.nlm.nih.gov/pubmed/32423130 http://dx.doi.org/10.3390/vaccines8020223 |
Ejemplares similares
-
The Immunogenicity and Anti-tumor Efficacy of a Rationally Designed Neoantigen Vaccine for B16F10 Mouse Melanoma
por: Zhang, Yan, et al.
Publicado: (2019) -
A PD-L1-Based Cancer Vaccine Elicits Antitumor Immunity in a Mouse Melanoma Model
por: Lin, Zhibing, et al.
Publicado: (2019) -
Targeting Costimulatory Molecules to Improve Antitumor Immunity
por: Capece, Daria, et al.
Publicado: (2012) -
γδ T cell costimulatory ligands in antitumor immunity
por: McGraw, Joseph M., et al.
Publicado: (2022) -
Antiproliferative effect of the jararhagin toxin on B16F10 murine melanoma
por: Maria, Durvanei Augusto, et al.
Publicado: (2014)